Covidien Snags Brain Monitor Co. Aspect For $210M
Dublin-based Covidien revealed the deal Monday in a joint statement.
The purchase will be followed by a second-step merger, which is expected to be completed by the end of 2009 after it meets closing conditions and regulatory approval, the statement said.
Both company boards have approved the transaction, in which a wholly owned subsidiary of Covidien will pay...
To view the full article, register now.